Georges Natsoulis

Title: Innovations of Georges Natsoulis

Introduction

Georges Natsoulis is a notable inventor based in Kensington, California. He has made significant contributions to the field of biotechnology, holding a total of five patents. His work primarily focuses on methods and apparatuses that enhance the understanding of biological responses and injuries.

Latest Patents

One of his latest patents involves the Peroxisome proliferation activated receptor alpha (PPARα) signatures. This invention includes methods for rapid testing and predicting a PPARα response, which is similar to that of PPARα agonists. The invention comprises a PPARα response signature made up of a set of twenty genes. It also discloses methods to predict whether a compound will induce a PPARα response in a test subject based on the differential expression of these genes. Another significant patent pertains to reagent sets and gene signatures for predicting the onset of renal tubule injury. This invention provides a necessary set of 186 genes that can generate signatures of varying size and performance to predict renal tubule injury. It also includes methods and reagents useful for predicting future renal tubule injury based on gene expression levels.

Career Highlights

Georges Natsoulis is currently associated with Entelos, Inc., where he continues to innovate and contribute to advancements in biotechnology. His work has been instrumental in developing predictive models that can significantly impact patient care and treatment strategies.

Collaborations

He has collaborated with notable coworkers such as Cecelia Pearson and Michael Furness, enhancing the research and development efforts at Entelos, Inc.

Conclusion

Georges Natsoulis exemplifies the spirit of innovation in biotechnology through his patents and contributions. His work not only advances scientific understanding but also holds the potential for significant clinical applications.